Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
Condition & Treatments
Search for a Condition or Treatment:
View allSearch

Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This


The Bone Health Program has been actively involved in exploring the causes and symptoms of pediatric low bone density and researching new and improved treatments. Researchers at Boston Children's Hospital are currently investigating:

  • Effect of Biomechanical Stimulation on Skeletal Health in Adolescent and Young Women with Anorexia Nervosa:
    A randomized, double-blind placebo-controlled trial to measure bone loss in the healthy adolescents with anorexia nervosa.

  • Sugar Sweetened Beverages and Cardiovascular Disease Risk:
    A randomized, double-blinded trial to compare the effects of three types of beverages on disease risk and body weight.

  • A Novel Diet-Phenotype Interaction Affecting Body Weight:
    How people with different blood insulin levels after consuming carbohydrate respond to different diets for weight loss is compared.

  • Use of Farnesyltransferase inhibitor (FTI) Lonafarnib for Hutchinson-Gilford Progeria Syndrome (HGPS) and progeroid laminopathies: 
    This protocol measures an experimental drug's effect using many tests in hopes that this drug will have therapeutic effect on progeria. 

  • PHACS (PH200) Adolescent Master Protocol (AMP):
    This protocol will look at problems in metabolism such as insulin resistance and diabetes (trouble with blood sugar) and mitochondrial changes that may lead to heart disease. 

  • Acute Lymphoblastic Leukemia (ALL)
  • Defining the Cause of Obesity in Narcolepsy
  • Clinical Study of Spinal Muscular Atrophy
  • Relation of Left Ventricular Mass to Lean Mass and Fat Mass
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO